This is the authors' abstract. We don't add key points for this paper.
Co-mutation analysis of RAS mutations in gynecologic cancers by cancer type (a) uterine, (b) ovarian, (c) cervical and vulvovaginal
No takes yet. Share an insight, caveat, or question.
Son et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: